Published in Proc Natl Acad Sci U S A on November 08, 1994
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A (1996) 3.29
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol (1995) 1.45
Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J Virol (1996) 1.33
Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors. J Virol (2006) 0.88
Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J Virol (1997) 0.83
Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization. Clin Diagn Lab Immunol (2001) 0.77
Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques. Clin Vaccine Immunol (2015) 0.76
Comparison of immune responses to intranasal and intrapulmonary vaccinations with the attenuated Mycoplasma hyopneumoniae 168 strain in pigs. J Vet Med Sci (2015) 0.75
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med (1981) 5.82
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene (1983) 3.94
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature (1984) 3.21
Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun (1993) 2.58
Vaccines for the Third World. Nature (1989) 2.58
Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol (1991) 2.48
Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun (1980) 2.35
A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine (1994) 2.22
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19
Immunisation with canarypox virus expressing rabies glycoprotein. Lancet (1992) 2.09
Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature (1987) 2.09
Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol (1991) 1.81
Recombinant vaccinia virus: immunization against multiple pathogens. Science (1985) 1.60
Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A (1986) 1.60
Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (1986) 1.45
Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology (1991) 1.44
The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol (1987) 1.41
Air-borne influenza virus A infections in immunized animals. Trans Assoc Am Physicians (1953) 1.22
Stimulation of secretory antibody following oral administration of antigen. Rev Infect Dis (1988) 1.01
Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine (1992) 0.93
Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine. Vaccine (1991) 0.93
Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol (1991) 0.93
Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model. Virus Res (1990) 0.83
[Oral and nasal immunization with Poxvirus vacciniae. 3. Animal experiments]. Zentralbl Bakteriol Orig B (1972) 0.81
Scarification with a vaccinia-influenza recombinant does not stimulate IgA unless the animals auto- or cross-inoculate their nasopharynxes. Vaccine (1993) 0.78
A family outbreak of oral accidental vaccinia. Arch Dermatol (1974) 0.78
Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science (1966) 3.88
Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med (1992) 3.63
The action of nitrous acid on p-cresol and tyrosine. Biochem J (1938) 3.62
The action of nitrous acid on pepsin. Biochem J (1938) 2.88
Adherence inhibition of Streptococcus mutans: an assay reflecting a possible role of antibody in dental caries prophylaxis. Infect Immun (1972) 2.86
Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol (1991) 2.48
Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun (1980) 2.44
Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun (1980) 2.35
Phylogeny of immunoglobulin structure and function. I. Immunoglobulins of the lemon shark. J Exp Med (1967) 2.31
Experimental IgA nephropathy. J Exp Med (1979) 2.09
Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. JAMA (1969) 2.08
Human alkaline phosphatase. Immunochemical identification of organ-specific isoenzymes. J Biol Chem (1968) 2.06
Polypeptide chain structure of rabbit immunoglobulins. I. gamma-G-immunoglobulin. Biochemistry (1966) 2.00
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85
Polypeptide chain structure of rabbit immunoglobulins. II. gamma-M-immunoglobulin. Biochemistry (1966) 1.84
Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol (1991) 1.81
Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect Immun (1979) 1.79
Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol (1983) 1.76
Antibody-mediated inhibition of dextran-sucrose-induced agglutination of Streptococcus mutans. Infect Immun (1974) 1.74
Polypeptide chain structure of rabbit immunoglobulins. 3. Secretory gamma-A-immunoglobulin from colostrum. Biochemistry (1967) 1.70
Influenza infection in ferrets: role of serum antibody in protection and recovery. Infect Immun (1976) 1.48
Heterotypic immunity to influenza in ferrets. Infect Immun (1980) 1.47
Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology (1991) 1.44
Local and systemic immunity to influenza infections in ferrets. Infect Immun (1978) 1.43
The actions of iodine and hypoiodous acid on pepsin. Biochem J (1939) 1.41
An evaluation of influenza immunization: influence of route of administration and vaccine strain. Bull World Health Organ (1969) 1.40
Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Immunology (1988) 1.40
7S gamma-M immunoglobulins in normal human cord serum. Am J Med Sci (1968) 1.36
Influenza virus. Curr Protoc Immunol (2001) 1.35
Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J Virol (1996) 1.33
Isolation and characterization of a mitogen from pokeweek (Phytolacca americana). Proc Natl Acad Sci U S A (1967) 1.32
Influenza: pathogenesis and host defense. Semin Respir Infect (1992) 1.27
Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J (1987) 1.26
Murine influenzal tracheitis: a model for the study of influenza and tracheal epithelial repair. Am Rev Respir Dis (1979) 1.25
Dissemination of influenza virus between anatomically isolated sites in ferrets. Infect Immun (1974) 1.25
Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol (1985) 1.14
Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J Infect Dis (1985) 1.10
Barbara, what's a nice girl like you doing writing an article like this? : the scientific basis of folk remedies for colds and flu. Chest (2000) 1.05
Virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan. Physiol Behav (1989) 1.04
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J Infect Dis (1994) 1.03
Antibody to Rat Kidney: In vivo Effects of Univalent and Divalent Fragments. Science (1963) 1.02
Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology (2000) 0.96
Peptide maps of rabbit gamma-G-immunoglobulin heavy chains controlled by allelic genes. J Mol Biol (1966) 0.95
Intranasal immunization with proteoliposomes protects against influenza. Vaccine (1989) 0.95
Electrophoretic heterogeneity of the polypeptide chains of human G-myeloma proteins. Science (1966) 0.94
Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine. Vaccine (1991) 0.93
Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest (1996) 0.93
Influenza infection in the infant mouse. Pediatr Res (1983) 0.92
Influenza antibody response following aerosal administration of inactivated virus. Am J Epidemiol (1970) 0.92
Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. J Clin Invest (1987) 0.92
Vitamin E supplementation decreases lung virus titers in mice infected with influenza. J Infect Dis (1997) 0.92
Disseminated Curvularia infection. Additional therapeutic and clinical considerations with evidence of medical cure. Arch Pathol Lab Med (1986) 0.92
Phylogeny of immunoglobulin structure and function. V. Valences and association constants of teleost antibodies to a haptenic determinant. J Exp Med (1970) 0.91
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome. Clin Exp Immunol (1986) 0.91
Colostral immunoglobulin-A: synthesis in vitro of T-chain by rabbit mammary gland. Science (1967) 0.91
Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. Vaccine (1995) 0.90
Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore Longitudinal Study of Aging. J Am Geriatr Soc (1986) 0.89
Fatal influenzal pneumonia in pregnancy: Failure to demonstrate transplacental transmission of influenza virus. Am J Obstet Gynecol (1980) 0.88
Heterotypic immune mice lose protection against influenza virus infection with senescence. J Infect Dis (1993) 0.88
Disseminated microsporidiosis especially infecting the brain, heart, and kidneys. Report of a newly recognized pansporoblastic species in two symptomatic AIDS patients. Am J Clin Pathol (1996) 0.86
Construction of an improved tracheal pouch in the ferret. Am Rev Respir Dis (1977) 0.85
Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes. Immunol Lett (1995) 0.85
Influenza infection of beta 2-microglobulin-deficient (beta 2m-/-) mice reveals a loss of CD4+ T cell functions with aging. J Immunol (1997) 0.84
Analysis of immune status of hemodialyzed adults: association with prior transfusions. Kidney Int (1984) 0.84
Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. Antiviral Res (1998) 0.84
Effect of long-term dietary antioxidant supplementation on influenza virus infection. J Gerontol A Biol Sci Med Sci (2000) 0.84
Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans. J Clin Lab Immunol (1986) 0.84
Digestion of anti-kidney antibody: effects on its nephrotoxicity and ability to fix complement. J Immunol (1965) 0.83
Age differences in phagocytosis by polymorphonuclear leukocytes measured by flow cytometry. J Leukoc Biol (1986) 0.83
Long-term urinary tract catheterization. Med Clin North Am (1989) 0.83
Immunoglobulin synthesis in neonatal nurse sharks (Ginglymostoma cirratum). Comp Biochem Physiol (1969) 0.83
Half-lives, body distribution and lack of interconversion of serum 19S and 7S IgM of sharks. J Immunol (1970) 0.82
Covalent aggregation of rabbit immunoglobulin G and liberation of free H and L chains in the absence of exogenous reducing agents. Biochim Biophys Acta (1967) 0.82
The association of E. coli peritonitis with an impaired and delayed fever response in senescent rats. J Gerontol (1992) 0.82
Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus. Vaccine (1994) 0.81
Conformation of immunologically-active fragments of sperm whale myoglobin in aqueous solution. J Mol Biol (1967) 0.81
Disseminated Curvularia infection. Arch Pathol Lab Med (1986) 0.81
Specific immunity to influenza virus in ferret organ cultures. Br J Exp Pathol (1978) 0.80
Modeling the relationship between clinical, microbiologic, and immunologic parameters and alveolar bone levels in an elderly population. J Periodontol (1994) 0.80
Tuberculosis: a growing concern for dentistry? J Am Dent Assoc (1993) 0.79
Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen. Clin Diagn Lab Immunol (2001) 0.79
Viral pneumonia attenuates adenylate cyclase but not beta-adrenergic receptors in murine lung. Am Rev Respir Dis (1989) 0.79
Respiratory allergy in the dog: induction by the respiratory route and the effect of passive antibody. Int Arch Allergy Appl Immunol (1977) 0.79
Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition. Microbios (1988) 0.79
New developments in infectious diarrhea. Dis Mon (1986) 0.78
Autopsies on two native American Mummies. Am J Phys Anthropol (1980) 0.78
The secretory immunological system of the fowl. VI. The effect of chemical bursectomy on immunoglobulin concentration in tears. Immunology (1978) 0.78
Scarification with a vaccinia-influenza recombinant does not stimulate IgA unless the animals auto- or cross-inoculate their nasopharynxes. Vaccine (1993) 0.78
Role of anaerobic bacteria in perimandibular space infections. Ann Otol Rhinol Laryngol Suppl (1991) 0.78
Recombinant vaccinia immunization in the presence of passively administered antibody. Vaccine (1993) 0.78
Local immunity against Newcastle disease virus in the newly hatched chicken's respiratory tract. Infect Immun (1977) 0.77
Effect of upper respiratory infection on hearing in the ferret model. Am J Otolaryngol (1987) 0.77
Microsporidia in humans. Ann Intern Med (1996) 0.76
Decline in rates of clearance of IgG-sensitized erythrocytes with increasing age. Blood (1988) 0.76
Enhancement of anti-influenza cytotoxic T-lymphocyte activity in senescent mice by vaccination early in life. Mech Ageing Dev (1990) 0.76